In animal models, activation of the sympathoadrenergic system through either stressful events or direct stimulation of β-AR usually leads to compromised resistance to tumor development and metastasis (Stefanski and Ben-Eliyahu, 1996; Shakhar and Ben-Eliyahu, 1998). This evidence concerns the gene ADRB2 and neoplasm.